solifenacin succinate

FDA Drug Profile — solifenacin succinate, VESIcare, Solifenacin succinate, VESIcare LS, Solifenacin Succinate

solifenacin succinate is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including solifenacin succinate, VESIcare, Solifenacin succinate. Available dosage forms: tablet, coated, tablet, film coated, tablet, film coated, extended release, powder, suspension.

Drug details

Generic Name
solifenacin succinate
Brand Names
solifenacin succinate, VESIcare, Solifenacin succinate, VESIcare LS, Solifenacin Succinate
Application Number
ANDA204374
Sponsor
Macleods Pharmaceuticals Limited
NDC Codes
22
Dosage Forms
TABLET, COATED, TABLET, FILM COATED, TABLET, FILM COATED, EXTENDED RELEASE, POWDER, SUSPENSION
Routes
ORAL
Active Ingredients
SOLIFENACIN SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Solifenacin succinate is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate is a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.